Weekly injectable pen for weight loss and metabolism support.
[[ selectedStrength ]] | Pharmaceutical-Grade
The first triple-agonist peptide — hitting three fat-loss pathways at once. In trials it outperformed every GLP-1 before it, including Ozempic, Wegovy and Mounjaro.
Ozempic and Wegovy hit one receptor. Mounjaro hits two. This is the first peptide to hit all three — appetite, metabolism and fat-burning at the same time.
The first triple-agonist peptide — hitting three fat-loss pathways at once. In trials it outperformed every GLP-1 before it, including Ozempic, Wegovy and Mounjaro.
Targets: Appetite · Cravings · Fat loss. Each vial contains 10 mg of lyophilized peptide at >90% purity, verified by independent HPLC analysis.
Most options hit one receptor. This one hits all three — appetite, metabolism and fat-burning at the same time.
Each vial contains 10 mg of lyophilized peptide at >90% purity. Your dose and scale-up are personalized and adjusted by your provider the whole way through.
This is a pharmaceutical-grade product. Every vial is batch tested and comes with an independent HPLC certificate of analysis. Discuss any concerns with your provider.
Guided titration supports steady results — no crash-diet whiplash, no plateaus you face alone.
Dispatched within 24 hours with delivery in 3 to 5 days.
Every batch is independently tested and verified for purity, verified with a Certificate of Analysis.
Shuts down the food noise and cravings that wreck every diet. The same pathway behind Ozempic and Wegovy — just doesn't stop there.
Improves how your body handles food and stores energy, amplifying the effect of every other pathway. The second lever Mounjaro added.
The one nobody else has. It raises your energy expenditure so you actively burn fat — not just eat less. This is the triple-agonist edge.
Quiets food noise
The GLP-1 arm shuts down the constant mental chatter about food — cravings fade and normal portions finally feel satisfying.
Steady, real results
Guided titration supports steady loss — no crash-diet whiplash, no plateaus you face alone.
Burns fat, not just appetite
The glucagon pathway raises your energy expenditure, so you lose fat actively instead of only eating less.
Built around you
Your dose and scale-up are personalized and adjusted by your provider the whole way through.
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situation evolves.
